Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
McMaster University · Impact · +17 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
472
total citations
- FWCI
- 30.85
- Percentile
- 100%
- References
- 265
Citations per year
Authors
53Topics & keywords
Topics
Keywords
- Kidney disease
- Medicine
- Homeostasis
- Kidney
- Intensive care medicine
- Internal medicine
No related works found for this paper.
Funding
- ALAbbott Laboratories
- AAmgen
- PPfizer
- AAstraZeneca
- BBayer
- SSanofi
- AAbbVie
- FFibroGen
- UOUniversity of Pittsburgh
- ACAstraZeneca Canada
- FMFresenius Medical Care North America
- BHBayer HealthCare
- NNNovo Nordisk
- APAstellas Pharma
- ATAkebia Therapeutics
- LPLEO Pharma
- NINational Institutes of Health
- ACAmgen Canada
- RRelypsa
- NINational Institute of Diabetes and Digestive and Kidney Diseases